The Protocol Review and Monitoring System (PRMS) in the University of Colorado Cancer Center’s Clinical Trials Office is under new leadership.
Greg Glasgow | 
January 30, 2023
Community Cancer Magazine Leadership
Two important numbers to keep in mind are that 50.5% of the U.S. population is female, and that cancer will account for more than 606,000 deaths in the United States this year, making it the second-leading cause of death.
Rachel Sauer | November 28, 2022
Yahoo News
January 26, 2023
Thomas Flaig, MD, has been named director of the Academic Urology Research Investigators Consortium, an oncology consortium for genito-urinary cancers.
Targeted Oncology
January 24, 2023
Thomas Flaig, MD, vice chancellor of research for CU Denver and CU Cancer Center member, discusses some of the current NCCN guidelines in bladder cancer.
Mirage News
January 18, 2023
About one out of every two Medicare patients with non-small cell lung cancer does not get the appropriate imaging before receiving radiation therapy.
OncLive
January 18, 2023
The 2022 San Antonio Breast Cancer Symposium highlighted research and treatments for HER2-negative, HER2-low, and HER2-positive breast cancer.
